Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in the Treatment of Coronary Artery Disease in Patients With Diabetes Mellitus

American Journal of Cardiology

Volumn 98, Issue 2, 2006, Pages 187-192

  Kuchulakanti, Pramod K ^a   Chu, William W ^a   Torguson, Rebecca ^a   Clavijo, Leonardo ^a   Wolfram, Roswitha ^a   Mishra, Sundeep ^a   Xue, Zhenyi ^a   Gevorkian, Natalie ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a Washington Hospital Center   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; INSULIN; PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DIABETIC PATIENT; DISEASE REGISTRY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; ECG ABNORMALITY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART DEATH; HEART EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL PATIENT; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESTENOSIS; SAMPLE SIZE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33745637046     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.074     Document Type: Article

References (26)

1. Mehran R., Dangas G.D., Kobayashi Y., Lansky A.J., Mintz G.S., Aymong E.D., Fahy M., Moses J.W., Stone G.W., and Leon M.B. Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol 43 (2004) 1348-1354
2. Mathew V., and Holmes Jr. D.R. Outcomes in diabetics undergoing revascularization. the long and short of it. J Am Coll Cardiol 40 (2002) 424-427
3. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation 96 (1997) 1761-1769
4. King S.B., Kosinski A.S., Guyton R.A., Lembo N.J., and Weintraub W.S. Eight year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am Coll Cardiol 35 (2000) 1116-1121
5. Van Belle E., Bauters C., Hubert E., Bodart J.C., Abolmaali K., Meurice T., McFadden E.P., Lablanche J.M., and Bertrand M.E. Restenosis rates in diabetic patients. a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96 (1997) 1454-1460
6. Elezi S., Kastrati A., Pache J., Wehinger A., Hadamitzky M., Dirschinger J., Neumann F.J., and Schomig A. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32 (1998) 1866-1873
7. Carrozza J.P.J., Kuntz R.E., Fishman R.F., and Baim D.S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 118 (1993) 344-349
8. Schofer J., Schluter M., Rau T., Hammer F., Haag N., and Mathey D.G. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients. a controlled study. J Am Coll Cardiol 35 (2000) 1554-1559
9. Suselbeck T., Latsch A., Siri H., Gonska B., Poerner T., Pfleger S., Schumacher B., Borggrefe M., and Haase K.K. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus. Am J Cardiol 88 (2001) 243-247
10. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
11. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., and Russell M.E. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
12. Abizaid A., Costa M.A., Blanchard D., Albertal M., Eltchaninoff H., Guagliumi G., Geert-Jan L., Abizaid A.S., Sousa A.G., Wuelfert E., et al., Ravel Investigators. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Euro Heart J 25 (2004) 107-112
13. Moussa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., Midwall J., Simonton C.A., Keim E., Wang P., et al. Impact of sirolimus-eluting stents on outcome in diabetic patients. Circulation 109 (2004) 2273-2278
14. Hermiller J.B., Raizner A., Cannon L., Gurbel P.A., Kutcher M.A., Wong S.C., Russell M.E., Ellis S.G., Mehran R., Stone G.W., and TAXUS-IV Investigators. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus. the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1172-1179
15. Kereiakes D.J., and Young J.J. Percutaneous coronary revascularization of diebetic patients in the era of drug-eluting stents. Rev Cardiovasc Med 6 (2005) S48-S58
16. Kuchulakanti P.K., Torguson R., Canos D., Rha S.W., Chu W.W., Clavijo L., Deible R., Gevorkian N., Suddath W.O., Satler L.F., et al. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients. Am J Cardiol 96 (2005) 1100-1106
17. Dibra A., Kastrati A., Mehilli J., Pache J., Schuhlen H., von Beckerath N., Ulm K., Wessely R., Dirschinger J., and Schomig A. ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
18. Corpus R.A., George P.B., House J.A., Dixon S.R., Ajluni S.C., Devlin W.H., Timmis G.C., Balasubramaniam M., and O'Neill W.W. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43 (2004) 8-14
19. Mehilli J., Kastrati A., Schuhlen H., Dibra A., Dotzer F., von Beckerath N., Bollwein H., Pache J., Dirschinger J., Berger P.P., and Schomig A. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation 110 (2004) 3627-3635
20. Abizaid A., Kornowski R., Mintz G.S., Hong M.K., Abizaid A.S., Mehran R., Pichard A.D., Kent K.M., Satler L.F., Wu H., et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32 (1998) 584-589
21. Schneider D.J., and Sobel B.E. Diabetes and thrombosis. Diabetes and Cardiovascular Disease (2001), Humana Press, Totowa, New Jersey 149-168
22. Schuhlen H., Kastrati A., Dirshinger J., Hausleiter J., Elezi S., Wehinger A., Pache J., Hadamitzky M., and Schomig A. Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 98 (1998) 104-111
23. Silva J.A., Ramee S., White C.J., Collins T.J., Jenkins J.S., Nunez E., Zhang S., and Jain S.P. Primary stenting in acute myocardial infarction. influence of diabetes mellitus in angiographic results and clinical outcome. Am Heart J 138 (1999) 446-455
24. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
25. Morice M.C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., and Stoll H.P. REALITY Trial Investigators. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
26. Ong A.T., Serruys P.W., Aoki J., Hoye A., van Mieghem C.A., Rodriguez-Granillo G.A., Valgimigli M., Sonnenschein K., Regar E., van der Ent M., et al. The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population. one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 45 (2005) 1135-1141